Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p
Skin Pharmacology and Physiology · 2025
DOI: 10.1159/000547809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Pharmacology and Physiology, 2025. Verfasst von Jianping He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Cicatrix, Hypertrophic, MicroRNAs. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Hypertrophic scars are common fibrotic disorders marked by fibroblast overgrowth and excessive extracellular matrix deposition, necessitating further research into their formation mechanisms to improve treatment outcomes. The study investigated the clinical significance and potential mechanisms of long noncoding RNA (lncRNA) HCP5 in the development of hypertrophic scars in human fibroblasts.
Methods
The study involved 63 patients to evaluate HCP5 expression through quantitative real-time PCR. Cellular behaviors of human hypertrophic scar myofibroblasts (HSFs) were measured using CCK-8, Transwell, and flow cytometry assays. Targeting interactions between lncRNA HCP5 and miR-27b-3p were verified using a dual-luciferase reporter assay.
Results
LncRNA HCP5 was significantly upregulated in hypertrophic scar tissue. More intriguingly, the silencing of lncRNA HCP5 led to a reduction in HSFs viability and migration, while simultaneously promoting apoptosis. Furthermore, miR-27b-3p was found to be downregulated and exhibited a negative correlation with lncRNA HCP5, both factors played crucial roles in regulating cellular behavior. In addition, the inhibition of miR-27b-3p may play a role in mitigating the effects induced by silenced lncRNA HCP5 on hypertrophic scars.
Conclusion
LncRNA HCP5 influenced the biological behavior of human hypertrophic scars by targeting miR-27b-3p.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Burn Department of Jinhua Central Hospital in Zhejiang Province, Jinhua, China.
- Dermatology Department, First Clinical Medical College of Yunnan University of Chinese Medicine, Kunming, China.
- Department of Plastic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China, hp15833218902@163.com.
Zitieren
APA
He, J., Xie, L., Zhang, Z., & Han, P. (2025). Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p. Skin Pharmacology and Physiology. https://doi.org/10.1159/000547809
Vancouver
He J, Xie L, Zhang Z, Han P. Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p. Skin Pharmacology and Physiology. 2025. doi:10.1159/000547809
BibTeX
@article{He2025,
author = {He, Jianping and Xie, Lanzhe and Zhang, Zhuo and Han, Peng},
title = {Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p},
journal = {Skin Pharmacology and Physiology},
year = {2025},
doi = {10.1159/000547809}
}
EUVIMED